(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -25.14%-1.27M | -1.01M |
Payments to suppliers for goods and services | -25.14%-1.27M | ---1.01M |
Direct interest received | 10,705.26%82.12K | --760 |
Operating cash flow | -17.12%-1.19M | ---1.01M |
Investing cash flow | ||
Cash flow from continuing investing activities | -144.10%-3.19M | -1.31M |
Capital expenditure reported | -136.53%-3.07M | ---1.3M |
Net PPE purchase and sale | -995.56%-126.45K | ---11.54K |
Cash from discontinued investing activities | ||
Investing cash flow | -144.10%-3.19M | ---1.31M |
Financing cash flow | ||
Cash flow from continuing financing activities | -9.44%5.17M | 5.71M |
Net common stock issuance | -9.44%5.17M | --5.71M |
Cash from discontinued financing activities | ||
Financing cash flow | -9.44%5.17M | --5.71M |
Net cash flow | ||
Beginning cash position | 4,235.48%3.47M | --79.99K |
Current changes in cash | -76.70%789.52K | --3.39M |
End cash Position | 22.77%4.26M | --3.47M |
Free cash from | -88.73%-4.38M | ---2.32M |
Accounting Standards | US-GAAP | US-GAAP |
No Data